Privia Health Group (PRVA) to Release Quarterly Earnings on Thursday

Privia Health Group (NASDAQ:PRVA) will release its earnings data before the market opens on Thursday, November 7th. Analysts expect Privia Health Group to post earnings of $0.05 per share for the quarter. Privia Health Group has set its FY 2024 guidance at EPS.Investors that are interested in participating in the company’s conference call can do so using this link.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.02). Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The business had revenue of $422.30 million during the quarter, compared to the consensus estimate of $411.50 million. During the same quarter in the previous year, the business earned $0.06 earnings per share. The firm’s revenue was up 2.2% compared to the same quarter last year. On average, analysts expect Privia Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Privia Health Group Stock Performance

PRVA stock opened at $19.22 on Tuesday. The firm has a 50 day moving average price of $18.37 and a 200-day moving average price of $18.28. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $24.35. The firm has a market capitalization of $2.30 billion, a price-to-earnings ratio of 160.17, a PEG ratio of 4.17 and a beta of 0.76.

Insiders Place Their Bets

In other news, CEO Parth Mehrotra sold 135,142 shares of Privia Health Group stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the transaction, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at $4,583,763.50. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 14.20% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on PRVA shares. Royal Bank of Canada reissued an “outperform” rating and issued a $28.00 target price on shares of Privia Health Group in a research report on Wednesday, August 14th. KeyCorp initiated coverage on shares of Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective for the company. Evercore ISI dropped their target price on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Finally, Robert W. Baird boosted their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, August 26th. Two analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Privia Health Group has an average rating of “Buy” and an average target price of $24.73.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.